Real-world management of infection during chemotherapy for acute leukemia in Japan: from the results of a nationwide questionnaire-based survey by the Japan Adult Leukemia Study Group

[1]  Dustin L. Stwalley,et al.  Effect of infectious disease consultation on mortality and treatment of patients with candida bloodstream infections: a retrospective, cohort study. , 2019, The Lancet. Infectious diseases.

[2]  A. Butler,et al.  Antimicrobial Stewardship in a Hematological Malignancy Unit: Carbapenem Reduction and Decreased Vancomycin-Resistant Enterococcus Infection. , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  H. Fukuda,et al.  Eight-Year Experience of Antimicrobial Stewardship Program and the Trend of Carbapenem Use at a Tertiary Acute-Care Hospital in Japan—The Impact of Postprescription Review and Feedback , 2019, Open forum infectious diseases.

[4]  P. Ljungman,et al.  Vaccination of patients with haematological malignancies who did not have transplantations: guidelines from the 2017 European Conference on Infections in Leukaemia (ECIL 7). , 2019, The Lancet. Infectious diseases.

[5]  S. Kutsuna,et al.  The impact of infectious disease consultation in candidemia in a tertiary care hospital in Japan over 12 years , 2019, PloS one.

[6]  M. Murad,et al.  Neutropenic diets to prevent cancer infections: updated systematic review and meta-analysis , 2019, BMJ Supportive & Palliative Care.

[7]  G. Maschmeyer,et al.  Management of febrile neutropenia in the perspective of antimicrobial de-escalation and discontinuation , 2019, Expert review of anti-infective therapy.

[8]  J. M. Rodriguez,et al.  Impact of Infectious Disease Consultation on Clinical Management and Mortality in Patients With Candidemia. , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  R. Humphries,et al.  Fluoroquinolone Prophylaxis Selects for Meropenem-nonsusceptible Pseudomonas aeruginosa in Patients With Hematologic Malignancies and Hematopoietic Cell Transplant Recipients. , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  M. Venditti,et al.  De-escalation and discontinuation strategies in high-risk neutropenic patients: an interrupted time series analyses of antimicrobial consumption and impact on outcome , 2018, European Journal of Clinical Microbiology & Infectious Diseases.

[11]  T. Naoe,et al.  Infectious complications in adults undergoing intensive chemotherapy for acute myeloid leukemia in 2001–2005 using the Japan Adult Leukemia Study Group AML201 protocols , 2018, Supportive Care in Cancer.

[12]  G. Guillerm,et al.  Early discontinuation of empirical antibacterial therapy in febrile neutropenia: the ANTIBIOSTOP study , 2018, Infectious diseases.

[13]  P. Bruzzi,et al.  Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines. , 2018, The Journal of infection.

[14]  T. Naoe,et al.  Management of infection during chemotherapy for acute leukemia in Japan: a nationwide questionnaire-based survey by the Japan Adult Leukemia Study Group , 2017, Supportive Care in Cancer.

[15]  C. Heussel,et al.  Serial assessment of pulmonary lesion volume by computed tomography allows survival prediction in invasive pulmonary aspergillosis , 2017, European Radiology.

[16]  M. Paul,et al.  Antibiotic de-escalation for bloodstream infections and pneumonia: systematic review and meta-analysis. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[17]  D. Denning,et al.  Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  K. Iwata,et al.  Is de-escalation of antimicrobials effective? A systematic review and meta-analysis. , 2016, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[19]  Matthew H Samore,et al.  Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  J. Sobel,et al.  Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  J. Sobel,et al.  Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  Y. Kanda,et al.  Efficacy and safety of tazobactam/piperacillin as an empirical treatment for the patients of adult and child with febrile neutropenia in Japan. , 2015, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[23]  G. Tomlinson,et al.  Impact of Infectious Disease Consultation on Quality of Care, Mortality, and Length of Stay in Staphylococcus aureus Bacteremia: Results From a Large Multicenter Cohort Study. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  J. Wingard,et al.  Combination Antifungal Therapy for Invasive Aspergillosis , 2015, Annals of Internal Medicine.

[25]  E. Anaissie,et al.  How we treat invasive fungal diseases in patients with acute leukemia: the importance of an individualized approach. , 2014, Blood.

[26]  D. Livermore,et al.  European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia , 2013, Haematologica.

[27]  K. Sepkowitz,et al.  Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  S. Ichiyama,et al.  Close cooperation between infectious disease physicians and attending physicians can result in better management and outcome for patients with Staphylococcus aureus bacteraemia. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[29]  T. Naoe,et al.  Management of infection in patients with acute leukemia during chemotherapy in Japan: questionnaire analysis by the Japan Adult Leukemia Study Group , 2009, International journal of hematology.

[30]  J. Sobel,et al.  Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  J. Perfect,et al.  Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. , 2007, The New England journal of medicine.

[32]  R. Foà,et al.  Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. , 2005, The New England journal of medicine.

[33]  L. Leibovici,et al.  Meta-Analysis: Antibiotic Prophylaxis Reduces Mortality in Neutropenic Patients , 2005, Annals of Internal Medicine.

[34]  R. Ohno,et al.  Current antimicrobial usage for the management of infections in leukemic patients in Japan: results of a survey. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.